CING Cingulate Inc. - Common Stock
NASDAQ · Pharmaceuticals · View on SEC EDGAR ↗ close Oct 2, 2026 10-K/10-Q May 14, 2026
$4.76
· of 52w range
· above low
· to high
$3.1652w low
$11.8952w high
Market Cap (MRQ)
$57M
your badges
52W Range
$3–$12
Analyst Rating
BUY
Price Target
$21
P/E
·
ROE
·
Net Profit Margin
·
Your badge strip is empty — pin a metric anywhere on this page.
CING Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$4.76
Market Cap (MRQ)
$57M
Debt/Equity (MRQ)
0.3
52W Range
$3–$12
CING Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
Stock splits
| Ex-date | Split | Type |
|---|---|---|
| Aug. 9, 2024 | 1-for-12 | Reverse |
| Nov. 30, 2023 | 1-for-20 | Reverse |
10-Year Performance Revenue, net income, margins and EPS trends
Valuation & Ratios
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
| Metric | 5Y trend | CING | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| P/B (MRQ) | 3.0 | · | 3.6 | Fair value |
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
Financial Health Debt, liquidity, solvency — balance sheet strength
| Metric | 5Y trend | CING | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Debt / Equity (MRQ) | 0.3 | · | 0.0 | High debt | |
| Current Ratio (MRQ) | 2.5 | · | 1.5 | Strong liquidity |
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
value · ≈ 5Y avg · industry median · verdict relative to median
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
-54.6%
| Period | Report | EPS Actual | EPS Est | Surprise |
|---|---|---|---|---|
| June 30, 2026 | Aug 13, 2026 | $-0.45 | $-0.64 | 29.4% |
| March 31, 2026 | May 14, 2026 | $-0.95 | $-0.46 | -108.5% |
| Dec. 31, 2025 | $-0.93 | $-0.64 | -44.6% | |
| Sept. 30, 2025 | $-1.35 | $-0.83 | -63.4% | |
| June 30, 2025 | $-1.09 | $-0.89 | -21.9% | |
| March 31, 2025 | $-1.04 | $-1.03 | -1.2% | |
| Dec. 31, 2024 | $-4.02 | $-1.48 | -171.8% |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
No annual filings for CING
We don't have SEC filings for this ticker yet.
Income Statement
| Metric | Trend | Q1 2026 | Q1 2025 |
|---|---|---|---|
| R&D Expense | $2M | $2M | |
| SG&A Expense | $6M | $1M | |
| Operating Income | $-8M | $-4M | |
| Pretax Income | $-9M | $-4M | |
| Net Income | $-9M | $-4M | |
| EPS (Basic) | $-0.95 | $-1.06 | |
| EPS (Diluted) | $-0.95 | $-1.06 | |
| Shares (Basic) | 9,777,786 | 3,646,893 | |
| Shares (Diluted) | 9,777,786 | 3,646,893 | |
| EBITDA | $-8M | · |
Balance Sheet
| Metric | Trend | Q1 2026 | Q1 2025 |
|---|---|---|---|
| Cash & Equivalents | $26M | · | |
| Prepaid Expense | $2M | · | |
| Current Assets | $28M | · | |
| PP&E (Net) | $2M | · | |
| PP&E (Gross) | $6M | · | |
| Accum. Depreciation | $4M | · | |
| Total Assets | $31M | · | |
| Accounts Payable | $3M | · | |
| Accrued Liabilities | $2M | · | |
| Short-term Debt | $6M | · | |
| Current Liabilities | $11M | · | |
| Capital Leases | $1M | · | |
| Total Liabilities | $12M | · | |
| Total Debt | $6M | · | |
| Common Stock | $1.2K | · | |
| Paid-in Capital | $161M | · | |
| Retained Earnings | $-142M | · | |
| Stockholders' Equity | $19M | · | |
| Liabilities + Equity | $31M | · | |
| Shares Outstanding | 11,908,316 | · |
Cash Flow
| Metric | Trend | Q1 2026 | Q1 2025 |
|---|---|---|---|
| Stock-based Comp | $593.1K | $357.6K | |
| Operating Cash Flow | $-7M | $-5M | |
| CapEx | $61.2K | · | |
| Investing Cash Flow | $-61.2K | · | |
| Stock Issued | $22M | $2M | |
| Net Stock Activity | $22M | · | |
| Financing Cash Flow | $22M | $2M | |
| Net Change in Cash | $15M | $-3M | |
| Free Cash Flow | $-7M | · |
Profitability
| Metric | Trend | Q1 2026 | Q1 2025 |
|---|---|---|---|
| Operating Margin | 1499.8% | · | |
| Net Margin | 1762.8% | · | |
| Pretax Margin | 1762.8% | · | |
| EBITDA Margin | 1499.8% | · | |
| ROA | -43.0% | · | |
| ROE | -75.1% | · |
Liquidity & Solvency
| Metric | Trend | Q1 2026 | Q1 2025 |
|---|---|---|---|
| Current Ratio | 2.5 | · | |
| Quick Ratio | 2.4 | · | |
| Debt / Equity | 0.3 | · |
Efficiency
| Metric | Trend | Q1 2026 | Q1 2025 |
|---|---|---|---|
| Asset Turnover | -0.0 | · |
Per Share
| Metric | Trend | Q1 2026 | Q1 2025 |
|---|---|---|---|
| Book Value / Share | $1.58 | · | |
| Revenue / Share | $-0.05 | · | |
| Cash Flow / Share | $-0.71 | · | |
| Cash / Share | $2.17 | · |
Valuation (TTM)
| Metric | Trend | Q1 2026 | Q1 2025 |
|---|---|---|---|
| Market Cap | $74M | · | |
| Enterprise Value | $54M | · | |
| P/B | 3.9 | · | |
| P / Tangible Book | 3.9 | · | |
| P / Cash Flow | -10.7 | · |
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
No data for this statement
Not enough fundamentals data to build this statement yet.
No data for this statement
Not enough fundamentals data to build this statement yet.
No data for this statement
Not enough fundamentals data to build this statement yet.
Institutional owners (13F) 39 filers · $13.3M total · As of June 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Holders
39
Value held
$13.3M
New positions
15
Exited positions
4
Institutional activity — Q2 2026 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 15 (+1 vs prior Q) | 4 (+1 vs prior Q) | 15 (+8 vs prior Q) | 4 (+1 vs prior Q) | +1.2M |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | $3,122,675 | 570,873 | 23.55% | Shares |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $1,195,742 | 218,600 | 9.02% | Put option |
| RAYMOND JAMES FINANCIAL INC | $912,932 | 166,898 | 6.88% | Shares |
| Chicago Partners Investment Group LLC | $911,996 | 188,429 | 6.88% | Shares |
| Kestra Advisory Services, LLC | $828,705 | 151,500 | 6.25% | Shares |
| GEODE CAPITAL MANAGEMENT, LLC | $791,371 | 144,636 | 5.97% | Shares |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $778,381 | 142,300 | 5.87% | Call option |
| RENAISSANCE TECHNOLOGIES LLC | $697,425 | 127,500 | 5.26% | Shares |
| VANGUARD GROUP INC | $657,220 | 151,433 | 4.96% | Shares |
| VANGUARD FIDUCIARY TRUST CO | $433,005 | 79,160 | 3.27% | Shares |
| JANE STREET GROUP, LLC | $294,286 | 53,800 | 2.22% | Call option |
| BlackRock, Inc. | $290,620 | 53,130 | 2.19% | Shares |
| BCV Asset Management Inc. | $272,943 | 51,200 | 2.06% | Shares |
| STATE STREET CORP | $261,947 | 47,888 | 1.98% | Shares |
| JANE STREET GROUP, LLC | $213,330 | 39,000 | 1.61% | Put option |
| CITADEL ADVISORS LLC | $208,407 | 38,100 | 1.57% | Put option |
| NORTHERN TRUST CORP | $192,112 | 35,121 | 1.45% | Shares |
| Quantum Private Wealth, LLC | $164,100 | 30,000 | 1.24% | Shares |
| Prospera Financial Services Inc | $163,552 | 29,900 | 1.23% | Shares |
| JANE STREET GROUP, LLC | $157,963 | 28,878 | 1.19% | Shares |
| UBS Group AG | $141,930 | 25,947 | 1.07% | Shares |
| Mariner, LLC | $116,405 | 21,281 | 0.88% | Shares |
| XTX Topco Ltd | $113,874 | 20,818 | 0.86% | Shares |
| CITADEL ADVISORS LLC | $97,913 | 17,900 | 0.74% | Call option |
| Jump Financial, LLC | $80,070 | 14,638 | 0.60% | Shares |
| PKS Advisory Services, LLC | $62,905 | 11,500 | 0.47% | Shares |
| Vanguard Global Advisers, LLC | $25,944 | 4,743 | 0.20% | Shares |
| MORGAN STANLEY | $23,319 | 4,263 | 0.18% | Shares |
| OSAIC HOLDINGS, INC. | $12,536 | 2,292 | 0.09% | Shares |
| IFP Advisors, Inc | $10,940 | 2,000 | 0.08% | Shares |
| JONES FINANCIAL COMPANIES LLLP | $9,920 | 2,000 | 0.07% | Shares |
| BARCLAYS PLC | $8,566 | 1,566 | 0.06% | Shares |
| WELLS FARGO & COMPANY/MN | $5,470 | 1,000 | 0.04% | Shares |
| Tower Research Capital LLC (TRC) | $2,593 | 474 | 0.02% | Shares |
| Rialto Wealth Management, LLC | $558 | 102 | 0.00% | Shares |
| SHP Wealth Management | $237 | 43 | 0.00% | Shares |
| Virtu Financial LLC | $66 | 12,056 | 0.00% | Shares |
| SBI Securities Co., Ltd. | $5 | 1 | 0.00% | Shares |
| Avion Wealth | $0 | 112 | 0.00% | Shares |
Activists & 5%+ owners 3 positions
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| Falcon Creek Capital Advisor LLC, Falcon Creek Technology Fund I, LP, Ginkgo Capital Global Fund SPC - Xtalpi AI Fund SP ×2 filings | March 26, 2026 | 28.50% | Amendment | · | SEC |
| Peter J. Werth, Werth Family Investment Associates LLC ×18 filings | Aug. 30, 2024 | · | Initial filing | · | SEC |
| Shane J. Schaffer, Fountainhead Shrugged, LLC ×5 filings | Jan. 4, 2024 | · | Initial filing | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Company insiders 19 insiders · 9 officers · 11 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Shane J. Schaffer | Chief Executive Officer | March 9, 2026 F | 4,076 | 2 | 0 | $34,862 |
| Jennifer L. Callahan | EVP and CFO | March 9, 2026 F | 13,961 | 2 | 0 | $24,904 |
| Louis G Van Horn | EVP and CFO | Feb. 28, 2023 A | 15,000 | 0 | 0 | $0 |
| Laurie Myers | EVP and COO | Feb. 18, 2025 A | 0 | 0 | 0 | $0 |
| Raul R. Silva | EVP and CSO | March 31, 2026 A | 4,645 | 0 | 0 | $0 |
| Nilay Dahyabhai Patel | EVP, CLO and CCO | March 9, 2026 F | 3,389 | 0 | 0 | $0 |
| Matthew Brams | EVP and Chief Medical Officer | March 9, 2026 F | 8,157 | 2 | 0 | $9,964 |
| Bryan Wade Downey | Chief Commercial Officer | Nov. 3, 2025 A | · | 0 | 0 | $0 |
| Craig S. Gilgallon | EVP and General Counsel | Feb. 28, 2023 A | 9,550 | 0 | 0 | $0 |
| Thomas Jeffrey Hargroves | Director | March 9, 2026 A | 97,468 | 2 | 0 | $498,053 |
| Peter J. Werth | Director | Feb. 6, 2026 P | 117,449 | 2 | 0 | $99,609 |
| Bryan Jay Lawrence | Director | June 12, 2024 A | · | 0 | 0 | $0 |
| Jeffrey S Ervin | Director | June 12, 2024 A | · | 0 | 0 | $0 |
| John A Roberts | Director | June 12, 2024 A | · | 0 | 0 | $0 |
| Curtis Medeiros | Director | June 15, 2023 A | 0 | 0 | 0 | $0 |
| Patrick Joseph Gallagher | Director | June 15, 2023 A | · | 0 | 0 | $0 |
| Scott Applebaum | Director | June 15, 2023 A | · | 0 | 0 | $0 |
| Gregg Wm Givens | Director | June 15, 2023 A | 154,318 | 0 | 0 | $0 |
| Jeffrey X Conroy | Director | Feb. 25, 2022 A | · | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
ETF ownership Held by 3 ETFs
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.
CING Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
rating · 10 analysts
BUY
Median target
$20.00
+320.2%
2 20.0%
Strong Buy
7 70.0%
Buy
1 10.0%
Hold
0 0.0%
Sell
0 0.0%
Strong Sell
12-Month Price Target
5 analysts · 2026-10-04Mean target $21.20 +345.4%
← Below all targets
Current price $4.76
Low$8.00
Mean$21.20
High$44.00
Peer comparison (GICS sub-industry) Key metrics vs sector peers
FY basis, prices as of each company's last fiscal year-end close.
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| CING | · | · | · | · | · | · |
| NTHI | · | -2.6 | -51.8% | · | · | · |
| CGTX | $120M | -4.2 | · | · | -113.7% | · |
| TELO | $46M | -4.0 | · | · | -325.7% | · |
| VRCA | $143M | -4.9 | 370.2% | -50.3% | -492.8% | · |
| RFL | · | -1.6 | 44.0% | -3328.2% | -34.6% | · |
| PLRX | $75M | -0.5 | -83.7% | · | -74.4% | · |
| ELOX | · | · | · | · | 30.1% | · |
| HYPD | $31M | -0.4 | 1318.8% | -5570.6% | -115.6% | 62.7% |
| TLPH | $56M | · | · | -51035.7% | -120.8% | · |
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Source: SEC 10-Q filed May 14, 2026